We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+4.42%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
AUM
$231M
AUM Growth
-$37.1M
Cap. Flow
-$48M
Cap. Flow %
-20.83%
Top 10 Hldgs %
50.4%
Holding
85
New
16
Increased
17
Reduced
31
Closed
20

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$7.59M
2
MRK icon
Merck
MRK
+$5.05M
3
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$3.65M
4
BAX icon
Baxter International
BAX
+$3.3M
5
IQV icon
IQVIA
IQV
+$3.29M

Sector Composition

Rank Sector Weight
1 Healthcare 93.59%
2 Financials 2.32%
3 Real Estate 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVTY icon
76
Revvity
RVTY
$12.6B
-19,041
Closed -$1.44M
TFX icon
77
Teleflex
TFX
$6.05B
-3,600
Closed -$918K
XRAY icon
78
Dentsply Sirona
XRAY
$2.68B
-13,200
Closed -$664K
RNTX
79
Rein Therapeutics
RNTX
$63.1M
-3,785
Closed -$615K
KA
80
DELISTED
Kineta, Inc. Common Stock
KA
-3,372
Closed -$2.24M
RETA
81
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-25,000
Closed -$513K
RDUS
82
DELISTED
Radius Health, Inc.
RDUS
-19,100
Closed -$686K
MDCO
83
DELISTED
Medicines Co
MDCO
-17,000
Closed -$560K
EVHC
84
DELISTED
Envision Healthcare Holdings Inc
EVHC
-82,174
Closed -$3.16M

Similar funds

Endurant Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Endurant Capital Management held 85 positions worth $231M, down 14% from $268M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Endurant Capital Management withdrew a net $48M in Q2 2018, closing 20 positions and reducing 31 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $3.16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 93% a quarter earlier, followed by Financials and Real Estate.

Against the trend, Endurant Capital Management opened a new position in IQVIA worth $3.29M.

  • Endurant Capital Management's largest Q2 2018 buy was IQVIA: 32,945 shares worth $3.29M.
  • Endurant Capital Management added most to Cigna in Q2 2018, an estimated $7.59M increase.
  • Endurant Capital Management's biggest Q2 2018 reduction was Boston Scientific, cutting an estimated $9.5M.
  • Endurant Capital Management fully exited Envision Healthcare Holdings Inc in Q2 2018, selling an estimated $3.16M.
  • Endurant Capital Management's ten largest holdings make up 50% of its $231M portfolio in Q2 2018.
  • Endurant Capital Management opened 16 new positions and closed 20 in Q2 2018.
  • Endurant Capital Management's portfolio value fell 14% quarter-over-quarter to $231M.

Based on Endurant Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.